MEDNAX Reports Fourth Quarter Results

Go back to MEDNAX Reports Fourth Quarter Results

MEDNAX (MD) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 EPS Mid-Point Guidance Below Consensus

February 20, 2020 6:19 AM EST

MEDNAX (NYSE: MD) reported Q4 EPS of $0.91, $0.01 better than the analyst estimate of $0.90. Revenue for the quarter came in at $905 million versus the consensus estimate of $901.2 million.

For the 2019 fourth quarter, MEDNAX reported the following results from continuing operations:

Net revenue of $905 million;Net income of $33 million; andAdjusted EBITDA of $132 million.

Our operating results for the fourth quarter were in line with our expectations, said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. 2019 was a year of significant organizational change, leadership restructuring and broad, aggressive transformational... More